Canine superficial bacterial folliculitis: current understanding of its etiology, diagnosis and treatment

The Veterinary Journal
Paul Bloom

Abstract

Superficial bacterial folliculitis (SBF) is more common in the dog than other mammalian species. Until recently, a successful outcome in cases of canine SBF was possible by administering a potentiated amoxicillin, a first generation cephalosporin or a potentiated sulfonamide. Unfortunately, this predictable susceptibility has changed, because methicillin resistant Staphylococcus pseudintermedius (MRSP) and Staphylococcus aureus (MRSA) are becoming more prevalent in canine SBF cases. The increasing frequency of multidrug resistance complicates the selection of antimicrobial therapy. Antimicrobial agents that were once rarely used in cases of canine SBF, such as amikacin, rifampicin and chloramphenicol, are becoming the drugs of choice, based on bacterial culture and susceptibility testing. Furthermore, changes in antimicrobial susceptibility have helped to re-emphasize the importance of a multimodal approach to treatment of the disease, including topical therapy. Due to the increasing frequency of identification of highly resistant Staphylococcus spp., topical antimicrobial therapy, including the use of diluted sodium hypochlorite (bleach), is becoming necessary to successfully treat some cases of canine SBF. Other important ant...Continue Reading

References

Oct 3, 1998·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·D L Monnet
Feb 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·N S CrowcroftR Mertens
Jun 6, 2000·The Journal of Antimicrobial Chemotherapy·K TrzcinskiC G Dowson
Sep 5, 2001·The Journal of Antimicrobial Chemotherapy·R A VeneziaE M Graffunder
May 15, 2002·Diagnostic Microbiology and Infectious Disease·L M DeshpandeUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group
Jun 1, 2002·The Journal of Small Animal Practice·C J Chesney
Feb 25, 2003·Journal of the American Veterinary Medical Association·Linda A FrankDavid A Bemis
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoUNKNOWN SHEA
Feb 27, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R ColodnerR Raz
Sep 10, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ronald E PolkMichael B Edmond
Mar 25, 2005·Journal of the American Veterinary Medical Association·Stephen D WhitePeter J Ihrke
Jul 15, 2005·International Journal of Systematic and Evolutionary Microbiology·Luc A DevrieseFreddy Haesebrouck
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Conan MacDougallRonald E Polk
Nov 7, 2006·Veterinary Dermatology·Andrew HillierJoseph J Kowalski
Jan 17, 2007·Journal of the American Veterinary Medical Association·Rebekah D JonesDavid A Bemis
Jun 29, 2007·Journal of Clinical Microbiology·Takashi SasakiKeiichi Hiramatsu
Aug 29, 2007·Antimicrobial Agents and Chemotherapy·Andrew E SimorUNKNOWN Canadian Nosocomial Infection Surveillance Program
Sep 30, 2008·The Journal of Antimicrobial Chemotherapy·A LoefflerD H Lloyd
Jan 14, 2009·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·David A BemisStephen A Kania
Feb 28, 2009·Veterinary Microbiology·J Scott Weese, Engeline van Duijkeren
Apr 21, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian S SchwartzHenry F Chambers
Sep 10, 2009·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Jennifer R SchisslerWondwossen A Gebreyes
Nov 3, 2009·Journal of the American Veterinary Medical Association·J Scott WeeseDurda Slavic
Jan 8, 2010·Journal of Clinical Microbiology·Takashi SasakiKeiichi Hiramatsu
Jan 11, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuHenry F Chambers
Mar 26, 2011·The Journal of Antimicrobial Chemotherapy·Kristina KadlecStefan Schwarz
Jul 23, 2011·Veterinary Dermatology·Rebecca YoungTim Nuttall
Jun 27, 2012·Veterinary Dermatology·Ralf S MuellerRoss Bond
Jun 29, 2012·American Journal of Veterinary Research·Mark G Papich
Jul 20, 2012·Veterinary Dermatology·Svenja C Budach, Ralf S Mueller

❮ Previous
Next ❯

Citations

Sep 14, 2011·BMC Veterinary Research·Evelyne MuggliKarl Nuss
Nov 29, 2016·Journal of Applied Microbiology·W BäumerK E Linder
Mar 15, 2020·Animals : an Open Access Journal From MDPI·Małgorzata JarosiewiczWojciech Kamysz
Feb 15, 2020·Microbiology Resource Announcements·Inga EichhornMarcus Fulde
Dec 3, 2021·PLoS Pathogens·Karen C CarrollLars F Westblade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.